Drug Trial Radar · NCT00946920
A Trial of Degarelix in Patients With Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Jun 2, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
859
Actual
Start
Jun 2009
Primary completion
Mar 2011
Study completion Mar 2011
Sponsor
- Lead sponsor
- Ferring PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jul 27, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.
Conditions
- Prostate Cancer
Interventions
DegarelixDrug
The degarelix doses were administered by subcutaneous (s.c.) injections into the abdominal wall. A starting dose of 240 mg degarelix was administered on Day 0. One month later a maintenance dose of 480 mg was administered. This was repeated after 4, 7, and 10 months (ie a total of 5 administrations).
Goserelin acetateDrug
The goserelin doses were administered by subcutaneous (s.c.) implants into the abdominal wall. An initial dose of 3.6 mg goserelin was administered on Day 0. One month later a subsequent dose of 10.8 mg was administered and this was repeated after 4, 7, and 10 months (ie a total of 5 implants).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative Probability of Testosterone at Castrate Level (≤0.5 ng/mL) With DegarelixTime frame: From Day 28 to Day 364
- Difference in Cumulative Probability of Testosterone at Castrate Level (≤0.5 ng/mL) Between Degarelix and GoserelinTime frame: Day 3 to Day 364
Locations
126 sites in 14 countries. Site status is shown where the registry gives one.
Urology Centers Of Alabama
Homewood, Alabama
Arkansas Urology
Little Rock, Arkansas
Urology Associates of Central CA
Fresno, California
Medresearch
La Mesa, California
South Orange County Medical Research Center
Laguna Hills, California
Atlantic Urology Medical Group
Long Beach, California
Anschutz Cancer Pavillion
Aurora, Colorado
The Urology Center of Colorado
Denver, Colorado
Urological Associates of Bridgeport, P.C.
Trumbull, Connecticut
Urology Associates of Dover, PA
Dover, Delaware
Walter Reed Army Medical Center
Washington D.C., District of Columbia
South Florida Medical Research
Aventura, Florida
Florida Foundation for Healthcare Research
Ocala, Florida
Georgis Patsias, MD, PA
Wellington, Florida
Palm Beach Urology Associates, PA
Wellington, Florida
Indiana University Department of Urology
Indianapolis, Indiana
Kansas City Urology Care, PA
Overland Park, Kansas
Urological Associates of Englewood
Englewood, New Jersey
Hamilton Urology PA
Hamilton, New Jersey
Lawrenceville Urology
Lawrenceville, New Jersey
Urology Group of New Mexico, PC
Albuquerque, New Mexico
Capital Region Urological Surgeons and Research Associates
Albany, New York
Hudson Valley Urology P.C.
Poughkeepsie, New York
Metrolina Urology Clinic
Charlotte, North Carolina
Northeast Urology Research
Concord, North Carolina
Duke University Medical Center
Durham, North Carolina
Alliance Urology Specialists
Greensboro, North Carolina
Urologic Consultants of SEPA
Bala-Cynwyd, Pennsylvania
State College Urologic Association
State College, Pennsylvania
Grand Strand Urology
Myrtle Beach, South Carolina
Urology Clinics of North Texas, PA
Dallas, Texas
Urology San Antonio Research
San Antonio, Texas
Urology of Virginia
Norfolk, Virginia
Virginia Urology Center
Richmond, Virginia
Urology of Virginia
Virginia Beach, Virginia
Seattle Urology Research Center
Burien, Washington
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Antwerpen
Edegem, Belgium
UZ Gent
Ghent, Belgium
AZ Groeninge - Campus Sint-Maarten
Kortrijk, Belgium
Showing 40 of 126 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.